Expanded Access Program – Daraxonrasib | Guidelines for Patients and Families
Important update for our previously treated metastatic pancreatic cancer (PDAC) patients: Date 4.5.2026 Time 15:15, written by Nir Erez Revolution Medicines received FDA authorization to open an Expanded Access Program…